🔎 Trials Near Me

Home › Kanser sa Cervix › Kentucky

Pag-aaral pangklinika para sa Kanser sa Cervix sa Kentucky

7 pag-aaral para sa Kanser sa Cervix ang naghahanap ng mga kalahok sa mga site sa Kentucky.

Mga Lungsod sa Kentucky

Opisyal na teksto ng pag-aaral (English)

Ocular Assessments in Patients Treated With Tivdak® in Recurrent or Metastatic Cervical Cancer

  • Norton Cancer Institute - Downtown, Louisville
  • Norton Hospital, Louisville
  • Norton Cancer Institute St Matthews Campus, Louisville
  • at 1 pa
Nagre-recruitPhase 4
Edad 18 pataas · Kababaihan · Na-update Nob 5, 2026 · NCT06952660

A Phase 1/2a Study of DB-1311/BNT324 in Advanced/Metastatic Solid Tumors

  • Research Site 115, Louisville
Nagre-recruitPhase 1/2
Edad 18 pataas · Lahat ng kasarian · Na-update Okt 21, 2026 · NCT05914116

Concurrent Immunotherapy and Systemic Therapy With Stereotactic Body Radiation Therapy (SBRT) for Stage IV Cancers (COINSSS IV)

  • University of Kentucky Markey Cancer Center, Lexington
Nagre-recruitPhase 2
Edad 18 hanggang 99 · Lahat ng kasarian · Na-update Okt 14, 2026 · NCT07770100

Evaluate BL-B01D1 in Patients With Metastatic or Unresectable Non-Small Cell Lung Cancer (NSCLC) and Other Solid Tumors

  • Norton Cancer Institute, Louisville
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Set 21, 2026 · NCT05983432

Hypofractionated Radiochemotherapy

  • Markey Cancer Center, Lexington
Nagre-recruitPhase 2
Edad 18 hanggang 120 · Kababaihan · Na-update Hul 30, 2026 · NCT06331468

A Trial of Robotic Versus Open Hysterectomy Surgery in Cervix Cancer

  • Baptist Health Lexington, Lexington
  • Baptist Health, Lexington
Nagre-recruit
Edad 18 pataas · Kababaihan · Na-update Hul 30, 2026 · NCT04831580

Safety and Tolerability of ²¹²Pb-DOTAM-GRPR1 in Adult Subjects With Recurrent or Metastatic GRPR-expressing Tumors

  • UK Markey Cancer Center, Lexington
Nagre-recruitPhase 1
Edad 18 pataas · Lahat ng kasarian · Na-update Hun 11, 2026 · NCT05283330

Mula sa ClinicalTrials.gov, na-kuha noong Nob 15, 2026. Ang bawat pag-aaral ay may sariling pamantayan sa eligibility; ang koponan ng pag-aaral ang magdedesisyon kung sino ang makakasali.